These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 9111037)
1. Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size. Rusnati M; Coltrini D; Oreste P; Zoppetti G; Albini A; Noonan D; d'Adda di Fagagna F; Giacca M; Presta M J Biol Chem; 1997 Apr; 272(17):11313-20. PubMed ID: 9111037 [TBL] [Abstract][Full Text] [Related]
2. The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists. Rusnati M; Tulipano G; Urbinati C; Tanghetti E; Giuliani R; Giacca M; Ciomei M; Corallini A; Presta M J Biol Chem; 1998 Jun; 273(26):16027-37. PubMed ID: 9632653 [TBL] [Abstract][Full Text] [Related]
3. Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides. Rusnati M; Tulipano G; Spillmann D; Tanghetti E; Oreste P; Zoppetti G; Giacca M; Presta M J Biol Chem; 1999 Oct; 274(40):28198-205. PubMed ID: 10497173 [TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular Tat. Rusnati M; Taraboletti G; Urbinati C; Tulipano G; Giuliani R; Molinari-Tosatti MP; Sennino B; Giacca M; Tyagi M; Albini A; Noonan D; Giavazzi R; Presta M FASEB J; 2000 Oct; 14(13):1917-30. PubMed ID: 11023976 [TBL] [Abstract][Full Text] [Related]
5. Cooperation of binding sites at the hydrophilic domain of cell-surface sulfatase Sulf1 allows for dynamic interaction of the enzyme with its substrate heparan sulfate. Milz F; Harder A; Neuhaus P; Breitkreuz-Korff O; Walhorn V; Lübke T; Anselmetti D; Dierks T Biochim Biophys Acta; 2013 Nov; 1830(11):5287-98. PubMed ID: 23891937 [TBL] [Abstract][Full Text] [Related]
6. Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat. Rusnati M; Urbinati C; Caputo A; Possati L; Lortat-Jacob H; Giacca M; Ribatti D; Presta M J Biol Chem; 2001 Jun; 276(25):22420-5. PubMed ID: 11304529 [TBL] [Abstract][Full Text] [Related]
7. Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins. Bugatti A; Urbinati C; Ravelli C; De Clercq E; Liekens S; Rusnati M Antimicrob Agents Chemother; 2007 Jul; 51(7):2337-45. PubMed ID: 17452490 [TBL] [Abstract][Full Text] [Related]
8. Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. Urbinati C; Bugatti A; Oreste P; Zoppetti G; Waltenberger J; Mitola S; Ribatti D; Presta M; Rusnati M FEBS Lett; 2004 Jun; 568(1-3):171-7. PubMed ID: 15196942 [TBL] [Abstract][Full Text] [Related]
9. Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters. Ziegler A; Seelig J Biophys J; 2004 Jan; 86(1 Pt 1):254-63. PubMed ID: 14695267 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of urokinase-type plasminogen activator by endogenous and exogenous HIV-1 Tat protein in tumour cell lines derived from BK virus/tat-transgenic mice. Rusnati M; Coltrini D; Campioni D; Tanghetti E; Corallini A; Barbanti-Brodano G; Giuliani R; Gibellini D; Presta M AIDS; 1997 May; 11(6):727-36. PubMed ID: 9143604 [TBL] [Abstract][Full Text] [Related]
11. Interaction of the transactivating protein HIV-1 tat with sulphated polysaccharides. Watson K; Gooderham NJ; Davies DS; Edwards RJ Biochem Pharmacol; 1999 Apr; 57(7):775-83. PubMed ID: 10075083 [TBL] [Abstract][Full Text] [Related]
12. Identification of cell-surface heparin/heparan sulfate-binding proteins of a human uterine epithelial cell line (RL95). Raboudi N; Julian J; Rohde LH; Carson DD J Biol Chem; 1992 Jun; 267(17):11930-9. PubMed ID: 1601862 [TBL] [Abstract][Full Text] [Related]
13. Heparin binding by the HIV-1 tat protein transduction domain. Hakansson S; Jacobs A; Caffrey M Protein Sci; 2001 Oct; 10(10):2138-9. PubMed ID: 11567105 [TBL] [Abstract][Full Text] [Related]
14. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication. Chen H; He J; Fong S; Wilcox G; Wood C J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286 [TBL] [Abstract][Full Text] [Related]
15. Structural and dynamic properties of the HIV-1 tat transduction domain in the free and heparin-bound states. Hakansson S; Caffrey M Biochemistry; 2003 Aug; 42(30):8999-9006. PubMed ID: 12885232 [TBL] [Abstract][Full Text] [Related]
16. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat. Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036 [TBL] [Abstract][Full Text] [Related]
17. Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site. Schafer SL; Vlach J; Pitha PM J Virol; 1996 Oct; 70(10):6937-46. PubMed ID: 8794337 [TBL] [Abstract][Full Text] [Related]
18. Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans. New insights from trypsin digestion studies. Coltrini D; Rusnati M; Zoppetti G; Oreste P; Isacchi A; Caccia P; Bergonzoni L; Presta M Eur J Biochem; 1993 May; 214(1):51-8. PubMed ID: 8508806 [TBL] [Abstract][Full Text] [Related]
19. Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA. Rhim H; Rice AP Nucleic Acids Res; 1994 Oct; 22(21):4405-13. PubMed ID: 7971271 [TBL] [Abstract][Full Text] [Related]
20. Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche. Gupta P; Oegema TR; Brazil JJ; Dudek AZ; Slungaard A; Verfaillie CM Blood; 1998 Dec; 92(12):4641-51. PubMed ID: 9845530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]